Results 81 to 90 of about 1,307,438 (325)

CDK11 inhibition induces cytoplasmic p21WAF1 splice variant by p53 stabilisation and SF3B1 inactivation

open access: yesMolecular Oncology, EarlyView.
CDK11 inhibition stabilises the tumour suppressor p53 and triggers the production of an alternative p21WAF1 splice variant p21L, through the inactivation of the spliceosomal protein SF3B1. Unlike the canonical p21WAF1 protein, p21L is localised in the cytoplasm and has reduced cell cycle‐blocking activity.
Radovan Krejcir   +12 more
wiley   +1 more source

Perfect codes in power graphs of finite groups

open access: yesOpen Mathematics, 2017
The power graph of a finite group is the graph whose vertex set is the group, two distinct elements being adjacent if one is a power of the other. The enhanced power graph of a finite group is the graph whose vertex set consists of all elements of the ...
Ma Xuanlong   +4 more
doaj   +1 more source

Power graphs: A survey

open access: yesElectronic Journal of Graph Theory and Applications, 2013
This article gives a survey of all results on the power graphs of groups and semigroups obtained in the literature. Various conjectures due to other authors, questions and open problems are also included.
Andrei V. Kelarev   +2 more
openaire   +4 more sources

The cochaperone BAG3 promotes the stabilization of p53 under heat stress conditions

open access: yesFEBS Open Bio, EarlyView.
Under heat stress, BAG3 translocates to the nucleus and forms a complex with Hsp70 and p53, thereby promoting p53 stabilization and enhancing its transcriptional activity. These findings suggest that BAG3 functions as a cochaperone that supports p53‐mediated stress responses in cooperation with Hsp70.
Ngoc Nguyen Thi Minh   +2 more
wiley   +1 more source

Critical classes of power graphs and reconstruction of directed power graphs

open access: yesJournal of Group Theory
Abstract In a graph Γ = ( V , E
Daniela Bubboloni, Nicolas Pinzauti
openaire   +3 more sources

Short‐term actions of epigalocatechin‐3‐gallate in the liver: a mechanistic insight into hypoglycemic and potential toxic effects

open access: yesFEBS Open Bio, EarlyView.
Epigallocatechin‐3‐gallate (EGCG) acutely inhibited gluconeogenesis and enhanced glycolysis, glycogenolysis, and fatty acid oxidation in perfused rat livers. Mechanistic assays revealed mitochondrial uncoupling, inhibition of pyruvate carboxylation and glucose‐6‐phosphatase, shift of NADH/NAD+ ratios toward oxidation, and loss of membrane integrity ...
Carla Indianara Bonetti   +8 more
wiley   +1 more source

On the tree-number of the power graph associated with some finite groups [PDF]

open access: yesAUT Journal of Mathematics and Computing
Given a group G, we define the power graph P(G) as follows: the vertices are the elements of G and two vertices x and y are joined by an edge if ⟨x⟩ ⊆ ⟨y⟩ or ⟨y⟩ ⊆ ⟨x⟩.
Sakineh Rahbariyan
doaj   +1 more source

Independence ratios of graph powers

open access: yesDiscrete Mathematics, 1994
Consider the limiting behaviour of the independence ratio of increasing cartesian powers of a graph. The authors observe that the limit always exists, and illustrate several situations in which the limit can be evaluated.
Huishan Zhou, Xingxing Yu, Pavol Hell
openaire   +2 more sources

HSP70 governs permeability and mechanotransduction in primary human endothelial cells

open access: yesFEBS Open Bio, EarlyView.
HSP70 chemical inhibition reduces endothelial cell proliferation and increases permeability, the latter supported by normal interendothelial junctional protein distribution. HSP70 also plays a role in shear stress response, a hemodynamic force naturally present in blood vessels and correlated with vessel protection.
Andrea Pinto‐Martinez   +5 more
wiley   +1 more source

Functional Connectivity Associations With Markers of Disease Progression in GRN Pathogenic Variant Carriers

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Autosomal dominant progranulin (GRN) pathogenic variants are a genetic cause of frontotemporal lobar degeneration. Though clinical trials for GRN‐related therapies are underway, there is an unmet need for biomarkers that can predict symptom onset and track disease progression.
Taru M. Flagan   +46 more
wiley   +1 more source

Home - About - Disclaimer - Privacy